MGH News (November 7, 2019): “Crosstalk” Between Genes Promotes Brain Inflammation in Alzheimer’s Disease

Thank you for being in touch about the recent Biogen announcement. We understand you have many questions about it and thank you for your patience. At this time, the information we have is similar to what you have read and heard.

There is a scientific meeting scheduled for December at which more data will be presented by the company. We expect to have more information after this meeting and will keep our patients and their family members updated as information continues to become available. We are working on providing live updates on our website and will share the information to access this as soon as we have it. The aducanumab trial is not currently enrolling patients.

Resize text-+=